Brookfield Asset Management Inc. Ptc Therapeutics, Inc. Transaction History

Brookfield Asset Management Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Sep 25, 2023	SELL	$40.4 - $59.1 $3.66 Million - $5.35 Million	-90,535 Reduced 86.78%	13,795 $561,000
Q2 2023 Aug 14, 2023	SELL	$40.4 - $59.1 $3.66 Million - $5.35 Million	-90,535 Reduced 86.78%	13,795 $561,000
Q1 2023 Sep 25, 2023	BUY	$38.16 - $48.86 $3.45 Million - $4.42 Million	90,535 Added 656.29%	104,330 $5.05 Million
Q1 2023 May 15, 2023	SELL	$38.16 - $48.86 $207,170 - $265,260	-5,429 Reduced 4.95%	104,330 $5.05 Million
Q4 2022 Feb 14, 2023	BUY	$33.53 - $54.79 $1.38 Million - $2.25 Million	41,024 Added 59.68%	109,759 $4.19 Million
Q3 2022 Nov 14, 2022	BUY	$41.85 - $53.85 $1.43 Million - $1.84 Million	34,150 Added 98.74%	68,735 $3.45 Million
Q2 2022 Nov 16, 2022	SELL	$25.6 - $45.23 $874,240 - $1.54 Million	-34,150 Reduced 49.68%	34,585 $1.39 Million
Q2 2022 Aug 15, 2022	SELL	$25.6 - $45.23 $215,680 - $381,062	-8,425 Reduced 19.59%	34,585 $1.39 Million
Q1 2022 May 16, 2022	BUY	$33.33 - $44.6 $1.43 Million - $1.92 Million	43,010 New	43,010 $1.6 Million

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.31B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.